Newsroom

Study compares peritoneal to hemodialysis used to treat end-stage kidney disease

April 2, 2014

Dr. Manish Sood has concluded a large scale study into the different types of dialysis used to treat end stage kidney disease in different regions of Canada. The study involved 31,778 patients in 56 health care facilities across 14 geographic regions, and found significant variations between in-hospital hemodialysis and peritoneal dialysis that is typically administered at home. Peritoneal dialysis, which has similar mortality rates to hemodialysis, allows for better quality of life and offers significant cost savings. Hemodialysis costs approximately $80,000 per patient per year whereas peritoneal dialysis costs about half that amount. Dr. Sood’s study found that Toronto had the highest rates of peritoneal dialysis at 36 per cent, followed by Vancouver at 33 per cent. The Atlantic provinces, excluding Nova Scotia, and eastern Ontario at 20 per cent each had lower rates of peritoneal dialysis utilization. See details in CMAJ Open.

Funders: Canadian Institutes of Health Research and The Kidney Foundation of Canada.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)
padmoore@ohri.ca